🚨“Ripping bacteria to shreds” 🚨 VCP/p97, a cellular AAA-ATPase, targets and then using its tweezer like action rips apart bacteria, protecting us from infections. A thread 🦠💥#MolecularMachines #HostDefense #cellularimmunity #microbiology
@natmicrobiol.nature.com
www.nature.com/articles/s41...
@natmicrobiol.nature.com
www.nature.com/articles/s41...
April 12, 2025 at 1:02 PM
🚨“Ripping bacteria to shreds” 🚨 VCP/p97, a cellular AAA-ATPase, targets and then using its tweezer like action rips apart bacteria, protecting us from infections. A thread 🦠💥#MolecularMachines #HostDefense #cellularimmunity #microbiology
@natmicrobiol.nature.com
www.nature.com/articles/s41...
@natmicrobiol.nature.com
www.nature.com/articles/s41...
This study shows heterologous #intranasal boosting with RBD-HR after mRNA priming enhances mucosal, humoral & #CellularImmunity against #SARSCoV2, inducing strong #NeutralizingAntibodies, SIgA, TRM cells & CD103⁺ DC activation.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
March 15, 2026 at 12:45 AM
This study shows heterologous #intranasal boosting with RBD-HR after mRNA priming enhances mucosal, humoral & #CellularImmunity against #SARSCoV2, inducing strong #NeutralizingAntibodies, SIgA, TRM cells & CD103⁺ DC activation.
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
The complementary mechanisms of humoral & #cellularimmunity induced by #Covid19vaccines. The results suggest that while neutralizing antibodies are crucial for effective viral control, #Tcell responses may offer an additional layer of protection when humoral responses are compromised.
June 15, 2025 at 12:09 PM
The complementary mechanisms of humoral & #cellularimmunity induced by #Covid19vaccines. The results suggest that while neutralizing antibodies are crucial for effective viral control, #Tcell responses may offer an additional layer of protection when humoral responses are compromised.
This review highlights strategies to evade anti rAAV #CellularImmunity, their advantages and limitations, and emerging technologies that could redefine #therapeutic innovation. #medsky
To read: doi.org/10.1007/s115...
To read: doi.org/10.1007/s115...
June 9, 2026 at 2:15 PM
This review highlights strategies to evade anti rAAV #CellularImmunity, their advantages and limitations, and emerging technologies that could redefine #therapeutic innovation. #medsky
To read: doi.org/10.1007/s115...
To read: doi.org/10.1007/s115...
Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses 🔬🧬✨ www.news-medical.net/news/2024070... #HIV #Research #Antiviral #SAMD9L #HIV1 #VirusInhibition #CellularImmunity #Interferon #Lentiviruses #ViralTranslation #Biomedical @plos.bsky.social
Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses
Researchers discovered that interferon-stimulated SAMD9L restricts HIV-1 and other lentiviruses by inhibiting viral translation and endosomal trafficking, while SAMD9 enhances HIV-1 replication.
www.news-medical.net
July 8, 2024 at 2:20 AM
Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses 🔬🧬✨ www.news-medical.net/news/2024070... #HIV #Research #Antiviral #SAMD9L #HIV1 #VirusInhibition #CellularImmunity #Interferon #Lentiviruses #ViralTranslation #Biomedical @plos.bsky.social
The study suggest this similar #cellularimmunity could provide equivalent protection against severe infection .
-Infection rates over 12 months: Control group 68.1%, Moderna 43.0%, Novavax 47.0%
*Vaccine Effectiveness Measurement
-Infection Detection Methods:
-Documented infections:
-Infection rates over 12 months: Control group 68.1%, Moderna 43.0%, Novavax 47.0%
*Vaccine Effectiveness Measurement
-Infection Detection Methods:
-Documented infections:
March 20, 2026 at 12:04 PM
The study suggest this similar #cellularimmunity could provide equivalent protection against severe infection .
-Infection rates over 12 months: Control group 68.1%, Moderna 43.0%, Novavax 47.0%
*Vaccine Effectiveness Measurement
-Infection Detection Methods:
-Documented infections:
-Infection rates over 12 months: Control group 68.1%, Moderna 43.0%, Novavax 47.0%
*Vaccine Effectiveness Measurement
-Infection Detection Methods:
-Documented infections:
#Cellularimmunity & #MolecularImmunology
Understanding & Overview the immune responses in asymptomatic #SarsCoV2 infection.
www.nature.com/articles/s41...
Understanding & Overview the immune responses in asymptomatic #SarsCoV2 infection.
www.nature.com/articles/s41...
January 16, 2024 at 1:42 PM
#Cellularimmunity & #MolecularImmunology
Understanding & Overview the immune responses in asymptomatic #SarsCoV2 infection.
www.nature.com/articles/s41...
Understanding & Overview the immune responses in asymptomatic #SarsCoV2 infection.
www.nature.com/articles/s41...
Congratulations to our team of CSI PIs for the NRF CRP grant award!
This is CSI Singapore's first PI-led CRP, with Prof. Yang Zhang as the lead PI and Dr. Jun Siong Low & Dr. Yang Li serving as co-investigators. 🏆
#AIinBiology #Immunology #CellularImmunity #TCellResearch
This is CSI Singapore's first PI-led CRP, with Prof. Yang Zhang as the lead PI and Dr. Jun Siong Low & Dr. Yang Li serving as co-investigators. 🏆
#AIinBiology #Immunology #CellularImmunity #TCellResearch
February 3, 2026 at 9:09 AM
Congratulations to our team of CSI PIs for the NRF CRP grant award!
This is CSI Singapore's first PI-led CRP, with Prof. Yang Zhang as the lead PI and Dr. Jun Siong Low & Dr. Yang Li serving as co-investigators. 🏆
#AIinBiology #Immunology #CellularImmunity #TCellResearch
This is CSI Singapore's first PI-led CRP, with Prof. Yang Zhang as the lead PI and Dr. Jun Siong Low & Dr. Yang Li serving as co-investigators. 🏆
#AIinBiology #Immunology #CellularImmunity #TCellResearch
Scientists develop a #RBDXBB15HR #vaccine inducing strong humoral and #CellularImmunity, boosting neutralization against #JN1 and #XBB subvariants, and showing protection against live #Omicron viruses—advancing next-gen #COVID19 vaccine strategies.
#STTT: doi.org/10.1038/s413...
#STTT: doi.org/10.1038/s413...
November 17, 2025 at 9:45 AM
Scientists develop a #RBDXBB15HR #vaccine inducing strong humoral and #CellularImmunity, boosting neutralization against #JN1 and #XBB subvariants, and showing protection against live #Omicron viruses—advancing next-gen #COVID19 vaccine strategies.
#STTT: doi.org/10.1038/s413...
#STTT: doi.org/10.1038/s413...
This review highlights #DNABasedVaccines as a next-gen platform enabling in situ antigen expression to elicit humoral and #CellularImmunity, outlining design, advantages, clinical progress, and potential for safe #immunization. @utoronto.ca
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...
January 20, 2026 at 12:45 AM
This review highlights #DNABasedVaccines as a next-gen platform enabling in situ antigen expression to elicit humoral and #CellularImmunity, outlining design, advantages, clinical progress, and potential for safe #immunization. @utoronto.ca
#OpenAccess: doi.org/10.1016/j.ge...
#OpenAccess: doi.org/10.1016/j.ge...